Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single... حسب Adam Gibb, Craig Jones, Adrian Bloor, Samar Kulkarni, Tim Illidge, Kim Linton, John Radford

احصل على النص الكامل